Clinical trials
Phase 3 Head and Neck Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 7 |
| Unknown status | 5 |
| Active, not recruiting | 3 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Royal Marsden NHS Foundation Trust | 2 |
| Adlai Nortye Biopharma Co., Ltd. | 1 |
| AstraZeneca | 1 |
| BioVex Limited | 1 |
| Boehringer Ingelheim | 1 |
| Bristol-Myers Squibb | 1 |
| Cancer Research UK | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Head and Neck Neoplasms | 29 |
| Squamous Cell Carcinoma of Head and Neck | 14 |
| Laryngeal Diseases | 3 |
| Carcinoma, Squamous Cell | 2 |
| Neoplasms | 2 |
| Radiation Injuries | 2 |
| Salivary Gland Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Adenocarcinoma, Follicular | 1 |
| Bronchial Diseases | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.